|
Monday, April 26, 2004
Salmedix Files for IPO
San Diego-based Salmedix has filed to raised up to $86M in an IPO. Salmedix is developing oncology drugs initially targeted at hematologic cancers, and is pre-revenue and is not expected to generate any revenue from the sale of its lead drug candidate for the foreseeable future. The IPO is being underwritten by SG Cowen, JMP Securities, Pacific Growth Equities, and ThinkEquity Partners.
posted on Monday, April 26, 2004 (Link to more information)
|
 RSS
 Email
Twitter
Previous news:
Monday, December 1, 2008
Wednesday, November 26, 2008
Tuesday, November 25, 2008
Monday, November 24, 2008
Friday, November 21, 2008
|
